BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17162011)

  • 1. Dietary fatty acids correlate with prostate cancer biopsy grade and volume in Jamaican men.
    Ritch CR; Wan RL; Stephens LB; Taxy JB; Huo D; Gong EM; Zagaja GP; Brendler CB
    J Urol; 2007 Jan; 177(1):97-101; discussion 101. PubMed ID: 17162011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of erythrocyte membrane polyunsaturated fatty acids and prostate-specific antigen levels in Jamaican men.
    Ritch CR; Brendler CB; Wan RL; Pickett KE; Sokoloff MH
    BJU Int; 2004 Jun; 93(9):1211-5. PubMed ID: 15180607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of fatty acids with prostate cancer risk.
    Newcomer LM; King IB; Wicklund KG; Stanford JL
    Prostate; 2001 Jun; 47(4):262-8. PubMed ID: 11398173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk.
    Chavarro JE; Stampfer MJ; Li H; Campos H; Kurth T; Ma J
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1364-70. PubMed ID: 17585059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dietary fatty acids and colorectal and prostate cancers: epidemiological studies].
    Astorg P
    Bull Cancer; 2005 Jul; 92(7):670-84. PubMed ID: 16123006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer.
    Krejcarek SC; Chen MH; Renshaw AA; Loffredo M; Sussman B; D'Amico AV
    Urology; 2007 Mar; 69(3):515-9. PubMed ID: 17382156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen velocity and prostate cancer gleason grade and stage.
    Pinsky PF; Andriole G; Crawford ED; Chia D; Kramer BS; Grubb R; Greenlee R; Gohagan JK
    Cancer; 2007 Apr; 109(8):1689-95. PubMed ID: 17330856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse association between prostatic polyunsaturated fatty acid and risk of locally advanced prostate carcinoma.
    Freeman VL; Meydani M; Hur K; Flanigan RC
    Cancer; 2004 Dec; 101(12):2744-54. PubMed ID: 15495177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate tissue and leukocyte levels of n-3 polyunsaturated fatty acids in men with benign prostate hyperplasia or prostate cancer.
    Christensen JH; Fabrin K; Borup K; Barber N; Poulsen J
    BJU Int; 2006 Feb; 97(2):270-3. PubMed ID: 16430627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth.
    Pandalai PK; Pilat MJ; Yamazaki K; Naik H; Pienta KJ
    Anticancer Res; 1996; 16(2):815-20. PubMed ID: 8687134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma.
    Godley PA; Campbell MK; Gallagher P; Martinson FE; Mohler JL; Sandler RS
    Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):889-95. PubMed ID: 8922296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acids and risk of prostate cancer in a nested case-control study in male smokers.
    Männistö S; Pietinen P; Virtanen MJ; Salminen I; Albanes D; Giovannucci E; Virtamo J
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1422-8. PubMed ID: 14693732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the risk of patients with biopsy Gleason score 6 to harbor a higher grade cancer.
    Gofrit ON; Zorn KC; Taxy JB; Lin S; Zagaja GP; Steinberg GD; Shalhav AL
    J Urol; 2007 Nov; 178(5):1925-8. PubMed ID: 17868725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer volume at biopsy predicts clinically significant upgrading.
    Dong F; Jones JS; Stephenson AJ; Magi-Galluzzi C; Reuther AM; Klein EA
    J Urol; 2008 Mar; 179(3):896-900; discussion 900. PubMed ID: 18207180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance.
    Nakanishi H; Groskopf J; Fritsche HA; Bhadkamkar V; Blase A; Kumar SV; Davis JW; Troncoso P; Rittenhouse H; Babaian RJ
    J Urol; 2008 May; 179(5):1804-9; discussion 1809-10. PubMed ID: 18353398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer.
    Punglia RS; Cullen J; McLeod DG; Chen Y; D'Amico AV
    Cancer; 2007 Nov; 110(9):1973-8. PubMed ID: 17886252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation.
    Maes M; Mihaylova I; Leunis JC
    Neuro Endocrinol Lett; 2005 Dec; 26(6):745-51. PubMed ID: 16380690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies.
    Kassouf W; Nakanishi H; Ochiai A; Babaian KN; Troncoso P; Babaian RJ
    J Urol; 2007 Jul; 178(1):111-4. PubMed ID: 17499289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic levels of fatty acids and the histopathology of localized prostate cancer.
    Freeman VL; Meydani M; Yong S; Pyle J; Flanigan RC; Waters WB; Wojcik EM
    J Urol; 2000 Dec; 164(6):2168-72. PubMed ID: 11061949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB.
    Bittner N; Merrick GS; Andreini H; Taubenslag W; Allen ZA; Butler WM; Anderson RL; Adamovich E; Wallner KE
    Urology; 2009 Jul; 74(1):171-6. PubMed ID: 19232691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.